Dengue Hemorrhagic Fever in Infants: A Study of Clinical and Cytokine Profiles

Journal of Infectious Diseases

Volumn 189, Issue 2, 2004, Pages 221-232

  Hung, Nguyen Thanh ^a   Lei, Huan Yao ^d   Lan, Nguyen Trong ^a   Lin, Yee Shin ^d   Huang, Kao Jean ^d   Lien, Le Bich ^a   Lin, Chiou Feng ^d   Yeh, Trai Ming ^d   Ha, Do Quang ^b   Huong, Vu Thi Que ^b   Chen, Lien Cheng ^d   Huang, Jyh Hsiung ^f   My, Lam Thi ^c   Liu, Ching Chuan ^e   Halstead, Scott B ^g  

^a Children's Hospital No 1   (Viet Nam)

^b PASTEUR INSTITUTE   (Viet Nam)

^c UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^f CENTER FOR DISEASE CONTROL   (Taiwan)

^g UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; PROTEIN C; PROTEIN S; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; HEMOCONCENTRATION; HUMAN; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROLOGY; SUPERINFECTION; THROMBOCYTOPENIA; WORLD HEALTH ORGANIZATION;

ANTIBODIES, VIRAL; BLOOD COAGULATION; CYTOKINES; DENGUE HEMORRHAGIC FEVER; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKIN-10; LIVER; PROTEIN C; PROTEIN S; TUMOR NECROSIS FACTOR-ALPHA;

EID: 9144248265     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/380762     Document Type: Article

References (33)

1. World Health Organization (WHO). Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd edition. Geneva: WHO, 1997.
2. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11:480-96.
3. World Health Organization (WHO). Dengue and dengue haemorrhagic fever. Fact sheet N.117. Geneva: WHO, 2002.
4. Halstead SB, Scanlon J, Umpaivit P, Udomsakdi S. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. IV. Epidemiologic studies in the Bangkok metropolitan area. Am J Trop Med Hyg 1969; 18:997-1021.
5. Kliks SC, Nimmannitya S, Nisalak A, Burke DS. Evidence that maternal antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988; 38:411-19.
6. Lan NT, Hung NT, Lien LB. Dengue hemorrhagic fever in infants [abstract 43]. In: Program and abstracts of the 4th International Symposium on Dengue Fever (Tahiti, French Polynesia). Geneva: World Health Organization, 1997:43.
7. Hidayah N, Darmowandowo W, Ismoedijanto, Soegijanto S. Dengue hemorrhagic fever in infant (clinical aspects, immunological responses related to the clinical degrees) [abstract]. In: Program and abstracts of the 1st International Conference on Dengue/Dengue Hemorrhagic Fever (Chiang Mai, Thailand). Geneva: World Health Organization, 2000:11.
8. Witayathawornwong P. Dengue hemorrhagic fever in infancy at Petchabun Hospital, Thailand. Southeast Asian J Trop Med Public Health 2001; 32:481-7.
9. Pancharoen C, Thisyakorn U. Dengue virus infection during infancy. Trans R Soc Trop Med Hyg 2001; 95:307-8.
10. Halstead SB, Lan NT, Myint TT, et al. Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis 2002; 8:1474-9.
11. Kurane I, Ennis FA. Immunopathogenesis of dengue virus infections. In: Gubler DJ, Kuno G, eds. Dengue and dengue haemorrhagic fever. Wallingford, Oxon, UK: CAB International, 1997:273-90.
12. Rothman AL, Ennis FA. Immunopathogenesis of dengue hemorrhagic fever. Virology 1999; 257:1-6.
13. Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC. Immunopathogenesis of dengue virus infection. J Biomed Sci 2001; 8:377-88.
14. Halstead SB. Enhanced dengue disease - epidemiological and experimental evidence. Presented at: Symposium on Accelerating the Development and Introduction of a Dengue Vaccine for Poor Children, Ho Chi Minh City, Vietnam, 5-8 December 2001.
15. Shu PY, Chen LK, Chang SF, et al. Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotvpe-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin Diagn Lab Immunol 2003; 10:622-30.
16. Lan NT. Experience in treatment of dengue shock syndrome [PhD thesis]. Ho Chi Minh City, Vietnam, The University of Medicine and Pharmacy-Ho Chi Minh City, 1994.
17. Hung NT, Lan NT Treatment of dengue hemorrhagic fever at Children's Hospital No. 1-Ho Chi Minh City, 1991-2000. Med J Ho Chi Minh City 2001; 3:149-52.
18. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. Liver biochemical tests and dengue fever. Am J Trop Med Hyg 1992; 47:265-70.
19. Nguyen TL, Nguyen TH, Tieu NT. The impact of dengue hemorrhagic fever on liver function. Res Virol 1997; 148:273-7.
20. Lan NT, Hung NT, Phuong BTM, et al. Treatment of dengue hemorrhagic fever at Children's Hospital No. 1-Ho Chi Minh City, 1991-1996. Dengue Bull 1998; 22:150-61.
21. Yadav M, Kamath KR, Iyngkaran K, Sinniah M. Dengue hemorrhagic fever and dengue shock syndrome - are they tumor necrosis factor-mediated disorders? FEMS Microbiol Immunol 1991; 4:45-9.
22. Vitarana T, de Silva H, Withana N, Gunasekera C. Elevated tumor necrosis factor in dengue fever and dengue hemorrhagic fever. Ceylon Med J 1991; 36:63-5.
23. Hober D, Poli L, Roblin B, et al. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) in dengue-infected patients. Am J Trop Med Hyg 1993; 48:324-31.
24. Hober D, Lan NT, Shen L, et al. Tumor necrosis factor alpha levels in plasma and whole-blood culture in dengue infected patients: relationship between virus detection and pre-existing specific antibodies. J Med Virol 1998; 54:210-8.
25. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Ennis FA. High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg 1993; 48:222-9.
26. Bethell DB, Flobbe K, Cao XT, et al. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 1998; 177:778-82.
27. Braga ELA, Moura P, Pinto LMO, et al. Detection of circulant tumor necrosis factor-α, soluble tumor necrosis factor p75 and interferon-γ in Brazilian patients with dengue fever and dengue hemorrhagic fever. Mem Inst Oswaldo Cruz 2001; 96:229-32.
28. Gagnon SJ, Mori M, Kurane I, et al. Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections. J Med Virol 2002; 67:41-6.
29. Kuno G, Bailey RE. Cytokine responses to dengue infection among Puerto Rican patients. Mem Inst Oswaldo Cruz 1994; 89:179-82.
30. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 2000; 63:71-5.
31. Juffrie M, Meer GM, Hack CE, et al. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg 2001; 65:70-5.
32. Suharti C, van Gorp ECM, Setiati TE, et al. The role of cytokine in activation and fibrinolysis in dengue shock syndrome. Thromb Haemost 2002; 87:42-6.
33. Green S, Pichyangkul S, Vaughn DW, et al. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis 1999; 180:1429-35.